SK Investment Vina III to hold 65 per cent of Imexpharm

SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.

Related Keywords

Vietnam ,Republic Of ,Germany ,Japan ,South Korea ,South Korean ,Vietnamese , ,Ibm ,Vietnam Mother Fund ,Service Holdingsb Vor Germany ,Sk Group ,Dragon Capital Group ,Fitch Solutions ,Sk Group South Korea ,General Meeting ,Nipro Pharma ,Holdingsb Vor ,Sk Investment Vina Iii ,Imexpharm ,Pharmaceutical ,